Excellent presentation by ⁦Mara Piltin⁩ ⭐️ Internal mammary lymphadenopathy does NOT impact oncologist outcome in pts treated with NAC from ⁦I-SPY 2⁩ ⁦👇🏼👇🏼👇🏼ASBrS⁩ #asbrs24

What an amazing summary of SABCS by ⁦Shelley Hwang⁩ ! 🤩🤩🤩 #asbrs24 ⁦ASBrS⁩ ⁦Duke Surgical Oncology⁩

Thank you ⁦Jennifer Gass⁩ , program planning committee and ⁦ASBrS⁩ for the opportunity to be on the podium today! Loved taking this #selfie on the podium 🤩🤩🤩 #ASBRS24 ⁦Duke Surgical Oncology⁩

⁦Anna Weiss⁩ presents on ⁦ASBrS⁩ survey result on axilla surgery of ypN+ 🔹ALND omission considered on cN0 and smaller nodal mets 🔹ALND reminds standard for ypN+ 🔹Awaiting A11202 result! #asbrs24 ⁦ASBrS⁩

Superb debate by ⁦PatrickIvanBorgen⁩ ⭐️⭐️⭐️ MRI should be performed for high risk (>20%) 🔹Diagnose earlier stage 🔹reduce interval cancer 🔹move pts away from risk reducing mastectomy👇🏼👇🏼👇🏼 ⁦ASBrS⁩ #Asbrs24 ⁦Maimonides Health⁩

Outstanding presentation by ⁦Zahraa Al-Hilli⁩ 🤩🤩🤩 Important discussion on Improving Risk-based Breast Cancer Screening Across Ethnicities. Black women more likely to have earlier diagnosis. Risk models less accurate for non white👇🏼👇🏼👇🏼 #asbrs24 ⁦ASBrS⁩

Great study using REQUITE database for QoL outcomes for women over 70 with breast cancer: choice of endocrine therapy matters ⁦ASBrS⁩ #ASBrS24

⁦Kristin E. Rojas MD, FACS, FACOG⁩ presented excellent summary of Fertility preservation in breast ca patients. 🔹Reproductive technology use do not increase recurrence or delay starting therapy. 👇🏼👇🏼👇🏼 #asbrs24 ⁦ASBrS⁩

Great talk by ⁦Kristin E. Rojas MD, FACS, FACOG⁩ about disparities in oncofertility care ⁦ASBrS⁩ #ASBrS24

Great study by ⁦Mara Piltin⁩ from I-SPY demonstrating internal mammary lymph node involvement in breast cancer not poor prognostic indicator with multidisciplinary management ⁦ASBrS⁩ #ASBrS24

Dr Kelly Hunt presents the best of ASCO! #asbrs24

It's a wrap! Thank you for joining us for #ASBRS24 . We'll see you next year for #ASBRS25 in Las Vegas.

Our future is looking bright! Wonderful engagement in our fellows lounge. #ASBrS24 #MedEd

Dr. Rojas busts myths around #oncofertility in breast cancer

Not only can fertility preservation be safely offered to women with breast cancer, it does not increase time to treatment.

#asbrs24

It’s time to update our counseling! BCT may have a better survival and has equivalent recurrence to mastectomy. #ASBRS24

For neoadjuvant endocrine therapy we first turn to the ACOSOG-Z1031 trial. NAET can inform decisions on adjuvant chemotherapy in synergy with genomic testing! #Asbrs24

🚫 difference in lymphedema rates w/ LVA (either by micro 🔬 LYMPHA or 👓 S-LYMPHA). N=115. More data and strategies needed❗️👏 excellent ASBrS presentation by innovative thinker James Jakub. #ASBrS24

Excellent Canadian 🇨🇦 study on young women w/ #BreastCancer by Katherine Fleshner 👏. Healthcare system working well and opportunities to educate young women re: signs/symptoms of breast cancer. ASBrS #ASBrS24

Great evening with Mayo alumni -what a great group #asbrs24 ⁦Mayo Clinic Department of Surgery⁩ ⁦James Jakub⁩ Mara Piltin⁩ ⁦Dr. Lillian Erdahl MD⁩ ⁦Robby Pride⁩ ⁦Akiko Chiba, MD, FACS⁩ ⁦Tony Nguyen⁩ ⁦Arielle Stafford, MD⁩ ⁦Miraj Shah-Khan, MD FACS⁩ ⁦Brittany Murphy⁩

Great posters from ⁦Mayo Clinic Department of Surgery⁩ ⁦Mayo Clinic Comprehensive Cancer Center⁩ presented at #asbrs24 last night. ⁦Tina J Hieken MD⁩